WO2016082807A3 - 伊曲康唑的新用途 - Google Patents
伊曲康唑的新用途 Download PDFInfo
- Publication number
- WO2016082807A3 WO2016082807A3 PCT/CN2016/072425 CN2016072425W WO2016082807A3 WO 2016082807 A3 WO2016082807 A3 WO 2016082807A3 CN 2016072425 W CN2016072425 W CN 2016072425W WO 2016082807 A3 WO2016082807 A3 WO 2016082807A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- itraconazole
- new use
- new
- hemangiomas
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供了伊曲康唑在制备治疗血管瘤的药物中的用途。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410707593.5 | 2014-11-28 | ||
| CN201410707593 | 2014-11-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2016082807A2 WO2016082807A2 (zh) | 2016-06-02 |
| WO2016082807A3 true WO2016082807A3 (zh) | 2016-07-21 |
Family
ID=56075085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2016/072425 Ceased WO2016082807A2 (zh) | 2014-11-28 | 2016-01-28 | 伊曲康唑的新用途 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN105640957B (zh) |
| WO (1) | WO2016082807A2 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020151666A1 (zh) * | 2019-01-25 | 2020-07-30 | 四川大学华西医院 | 血管瘤治疗的生物标记物 |
| CN110279696A (zh) * | 2019-07-31 | 2019-09-27 | 中国医学科学院皮肤病医院 | 伊曲康唑在制备抑制肿瘤转移药物中的应用 |
| CN115980357A (zh) * | 2022-09-09 | 2023-04-18 | 齐霁 | 一种抗真菌药伊曲康唑的抗血管新生方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711156A (zh) * | 2007-04-05 | 2010-05-19 | 约翰·霍普金斯大学 | 作为血管新生抑制剂的伊曲康唑的手性纯的异构物及羊毛甾醇14a-去甲基酶的抑制剂 |
-
2015
- 2015-11-27 CN CN201510852228.8A patent/CN105640957B/zh not_active Expired - Fee Related
-
2016
- 2016-01-28 WO PCT/CN2016/072425 patent/WO2016082807A2/zh not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711156A (zh) * | 2007-04-05 | 2010-05-19 | 约翰·霍普金斯大学 | 作为血管新生抑制剂的伊曲康唑的手性纯的异构物及羊毛甾醇14a-去甲基酶的抑制剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105640957A (zh) | 2016-06-08 |
| WO2016082807A2 (zh) | 2016-06-02 |
| CN105640957B (zh) | 2020-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272820A (en) | History of sulfamolepyrolamide and their use as hepatitis B drugs | |
| EP3154594A4 (en) | Fap-activated therapeutic agents, and uses related thereto | |
| EP3170467A4 (en) | Ultrasonic vibrator for medical treatment | |
| IL254142B (en) | Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent | |
| EP3188721A4 (en) | Human therapeutic agents | |
| EP3148526A4 (en) | Use of eribulin in the treatment of cancer | |
| EP3154438A4 (en) | Therapeutic ultrasound breast treatment | |
| EP2905006B8 (fr) | Dispositif de discrimination des stades de sommeil d'un patient. | |
| IL252897A0 (en) | Indanyl compounds, pharmaceutical preparations and their medical uses | |
| IL247969B (en) | A medicinal component for use in the treatment of infections | |
| PH12017501071B1 (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
| WO2016082807A3 (zh) | 伊曲康唑的新用途 | |
| ZA201802399B (en) | Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use in the treatment of cancer | |
| EP3145525A4 (en) | Use of microperoxidases for the treatment of carboxyhemoglobinemia | |
| EP3694391B8 (en) | Device for use in the treatment of hemorrhoids | |
| EP3479785A4 (en) | MEDICAL TREATMENT DEVICE | |
| EP3184055A4 (en) | Medical treatment instrument | |
| HK40111840A (zh) | 用於治疗运动机能亢进性运动障碍的valbenazine给药方案 | |
| EP3094330A4 (en) | Treatment of crohn's disease using low doses of laquinimod | |
| HK40052182B (zh) | 六氢咪唑并吡啶并嘧啶酮、其类似物和盐、及其治疗用途 | |
| IL251930A0 (en) | Anylhydroxy derivatives, their preparation and medical uses | |
| AU2016902139A0 (en) | New Therapeutic Treatment Combination | |
| HK1248110A1 (zh) | 用於治疗braf-v600相关的疾病的plx-8394或plx-7904 | |
| AU2014902075A0 (en) | New Therapeutic Treatment Combination | |
| AU2015902062A0 (en) | New Therapeutic Treatment Combination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16724838 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16724838 Country of ref document: EP Kind code of ref document: A2 |